$LGIQ
Logiq Inc

2023 Q4 Form 10-Q Financial Statement

#000157587223001754 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $0.00 $3.266M
YoY Change -100.0% -20.36%
Cost Of Revenue $0.00 $3.208M
YoY Change -100.0% 14.87%
Gross Profit $0.00 $57.97K
YoY Change -100.0% -95.57%
Gross Profit Margin 1.78%
Selling, General & Admin $16.05M $3.257M
YoY Change 2472.15% -57.48%
% of Gross Profit 5618.1%
Research & Development $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit 0.0%
Depreciation & Amortization -$1.136M $690.0K
YoY Change -114.36% 4926.22%
% of Gross Profit 1190.31%
Operating Expenses $16.41M $3.946M
YoY Change 37.62% -56.17%
Operating Profit -$16.41M -$3.888M
YoY Change 44.96% -49.47%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 -$46.39K
YoY Change -100.0% -1546466.67%
Pretax Income -$16.41M -$3.930M
YoY Change -47.11% -48.93%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$20.10M -$3.934M
YoY Change -35.23% -48.87%
Net Earnings / Revenue -120.48%
Basic Earnings Per Share -$0.04
Diluted Earnings Per Share -$0.20 -$0.04
COMMON SHARES
Basic Shares Outstanding 147.0M 103.0M
Diluted Shares Outstanding 101.7M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.86K $390.0K
YoY Change -96.43% 5.9%
Cash & Equivalents $16.86K $392.9K
Short-Term Investments
Other Short-Term Assets $152.0K $80.00K
YoY Change -45.66% -89.7%
Inventory
Prepaid Expenses $152.0K $84.22K
Receivables $600.0K
Other Receivables $482.4K $482.4K
Total Short-Term Assets $651.3K $1.555M
YoY Change -72.88% -62.09%
LONG-TERM ASSETS
Property, Plant & Equipment $53.05K
YoY Change -53.8%
Goodwill $5.578M
YoY Change 0.0%
Intangibles $0.00 $5.622M
YoY Change -100.0% -52.16%
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $0.00 $11.25M
YoY Change -100.0% -35.5%
TOTAL ASSETS
Total Short-Term Assets $651.3K $1.555M
Total Long-Term Assets $0.00 $11.25M
Total Assets $651.3K $12.81M
YoY Change -95.71% -40.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $992.0K $2.944M
YoY Change -80.45% -22.18%
Accrued Expenses $50.00K $2.550M
YoY Change -97.71% -23.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.042M $5.498M
YoY Change -86.14% -24.84%
LONG-TERM LIABILITIES
Long-Term Debt $10.00K $10.00K
YoY Change 0.0% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $10.00K $10.00K
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.042M $5.498M
Total Long-Term Liabilities $10.00K $10.00K
Total Liabilities $1.052M $5.508M
YoY Change -86.03% -24.81%
SHAREHOLDERS EQUITY
Retained Earnings -$131.8M -$151.4M
YoY Change 0.3% 50.78%
Common Stock $14.39K $12.94K
YoY Change 160.99% 251.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$400.7K $7.300M
YoY Change
Total Liabilities & Shareholders Equity $651.3K $12.81M
YoY Change -95.71% -40.56%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$20.10M -$3.934M
YoY Change -35.23% -48.87%
Depreciation, Depletion And Amortization -$1.136M $690.0K
YoY Change -114.36% 4926.22%
Cash From Operating Activities $992.9K -$2.710M
YoY Change -120.92% -31.45%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$2.420K $0.00
YoY Change
Cash From Investing Activities -$2.420K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.366M 2.600M
YoY Change -128.27% -33.76%
NET CHANGE
Cash From Operating Activities 992.9K -2.710M
Cash From Investing Activities -2.420K 0.000
Cash From Financing Activities -1.366M 2.600M
Net Change In Cash -375.3K -110.0K
YoY Change -547.21% 291.18%
FREE CASH FLOW
Cash From Operating Activities $992.9K -$2.710M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001335112
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-51815
dei Entity Registrant Name
EntityRegistrantName
LOGIQ INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5057897
dei Entity Address Address Line1
EntityAddressAddressLine1
230 Victoria Street Bugis Junction
dei Entity Address Address Line2
EntityAddressAddressLine2
#15-01/08
dei Entity Address City Or Town
EntityAddressCityOrTown
Singapore
dei Entity Address Country
EntityAddressCountry
SG
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
188024
dei City Area Code
CityAreaCode
65
dei Local Phone Number
LocalPhoneNumber
9366 2322
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
147005621
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5622156
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7119111
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53052
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85430
CY2023Q3 us-gaap Goodwill
Goodwill
5577926
CY2022Q4 us-gaap Goodwill
Goodwill
5577926
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
11253134
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
12782467
CY2023Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
595323
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1649632
CY2023Q3 lgiq Right To Use Assets Operating Leases
RightToUseAssetsOperatingLeases
0
CY2022Q4 lgiq Right To Use Assets Operating Leases
RightToUseAssetsOperatingLeases
58122
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
84224
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
221591
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
482420
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
0
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
392853
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
472206
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1554820
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2401551
CY2023Q3 us-gaap Assets
Assets
12807954
CY2022Q4 us-gaap Assets
Assets
15184018
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2943738
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5073315
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
2553856
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
2169893
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16589
CY2023Q3 us-gaap Deposit Liability Current
DepositLiabilityCurrent
0
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
260220
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5497594
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7520017
CY2023Q3 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
10000
CY2022Q4 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
10000
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10000
CY2023Q3 us-gaap Liabilities
Liabilities
5507594
CY2022Q4 us-gaap Liabilities
Liabilities
7530017
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
129379314
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
129379314
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55118520
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55118520
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
12938
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5512
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110405098
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
94829417
CY2023Q3 lgiq Capital Reserves
CapitalReserves
48243604
CY2022Q4 lgiq Capital Reserves
CapitalReserves
44232194
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-151361280
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-131413122
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
7300360
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7654001
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12807954
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15184018
CY2023Q3 us-gaap Revenues
Revenues
3265674
CY2022Q3 us-gaap Revenues
Revenues
4100373
us-gaap Revenues
Revenues
11663762
us-gaap Revenues
Revenues
17155733
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
3207706
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
2792499
us-gaap Cost Of Revenue
CostOfRevenue
10790605
us-gaap Cost Of Revenue
CostOfRevenue
11823582
CY2023Q3 lgiq Gross Income
GrossIncome
57968
CY2022Q3 lgiq Gross Income
GrossIncome
1307874
lgiq Gross Income
GrossIncome
873157
lgiq Gross Income
GrossIncome
5332151
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
689318
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1021676
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1529331
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3083536
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3256702
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7265372
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18945206
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16504135
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
0
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
394628
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
214715
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1266029
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
321000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2617178
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
3946020
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
9002676
us-gaap Operating Expenses
OperatingExpenses
20689252
us-gaap Operating Expenses
OperatingExpenses
23470878
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3888052
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7694802
us-gaap Operating Income Loss
OperatingIncomeLoss
-19816095
us-gaap Operating Income Loss
OperatingIncomeLoss
-18138727
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-46391
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-132063
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2563
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-3934443
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-7694799
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-19948158
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-18136164
CY2023Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3934443
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7694799
us-gaap Net Income Loss
NetIncomeLoss
-19948158
us-gaap Net Income Loss
NetIncomeLoss
-18136164
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0387
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0387
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.2221
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2221
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.2318
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2318
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.5805
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.5805
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101745947
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101745947
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34645067
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34645067
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86068463
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86068463
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31241330
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31241330
us-gaap Net Income Loss
NetIncomeLoss
-19948158
us-gaap Net Income Loss
NetIncomeLoss
-18136164
us-gaap Depreciation
Depreciation
32378
us-gaap Depreciation
Depreciation
39141
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1496955
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3044395
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1054309
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1010137
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-137367
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-99428
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-2129577
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
1488965
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
383963
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1486482
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
41533
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-9795
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18931230
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10977411
lgiq Increase Decrease In Amount Due From Associate
IncreaseDecreaseInAmountDueFromAssociate
0
lgiq Increase Decrease In Amount Due From Associate
IncreaseDecreaseInAmountDueFromAssociate
-7208700
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
482420
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
0
lgiq Payments To Acquire Financial Assets Held For Resale
PaymentsToAcquireFinancialAssetsHeldForResale
0
lgiq Payments To Acquire Financial Assets Held For Resale
PaymentsToAcquireFinancialAssetsHeldForResale
-681
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-482420
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7209381
lgiq Proceeds From Shares To Be Issueds
ProceedsFromSharesToBeIssueds
-260220
lgiq Proceeds From Shares To Be Issueds
ProceedsFromSharesToBeIssueds
-212778
lgiq Proceeds From Share Issuance For Services Received And Cash Received Net Of Expenses
ProceedsFromShareIssuanceForServicesReceivedAndCashReceivedNetOfExpenses
19594517
lgiq Proceeds From Share Issuance For Services Received And Cash Received Net Of Expenses
ProceedsFromShareIssuanceForServicesReceivedAndCashReceivedNetOfExpenses
2782821
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19334297
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2570043
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-79353
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1197987
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
472206
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1586265
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
392853
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
388278
lgiq Issuance Of Shares For Services Received
IssuanceOfSharesForServicesReceived
14135579
lgiq Issuance Of Shares For Services Received
IssuanceOfSharesForServicesReceived
5969804
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7654001
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14156150
CY2023Q1 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
0
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-12448500
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9361651
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2829439
CY2023Q2 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
0
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-3565215
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8625875
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2608928
CY2023Q3 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
0
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-3934443
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
7300360
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29575321
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-2784618
CY2022Q1 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
-13
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-3980524
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22810166
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1741423
CY2022Q2 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
0
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-6460841
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
18090748
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3826029
CY2022Q3 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
0
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-7694799
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
14221978
CY2021Q4 lgiq App Logiq Spinoff Description
AppLogiqSpinoffDescription
GoLogiq is a fully reporting U.S. public company. In connection with the Separation, the Company announced that it intended to distribute, on a pro rata basis, 100%
CY2022Q1 lgiq App Logiq Spinoff Description
AppLogiqSpinoffDescription
The Company held the GoLogiq Shares until it distributed 100% of the GoLogiq Shares to the Company’s stockholders of record as of December 30, 2021 on a 1-for-1 basis (i.e. for every 1 share of Logiq held on December 30, 2021, the holder thereof will receive 1 share of Lovarra)
lgiq Data Logiq Spinoff Description
DataLogiqSpinoffDescription
At Closing Abri will deliver to the Company $114 million worth of shares Abri common stock, par value $0.0001, at $10.00 per share (the “Merger Consideration Shares”). Also at Closing, the Company will issue a dividend to its shareholders on a pro-rata basis equal to 25% of the aggregate Merger Consideration Shares (the “Dividend Shares”), payable to the Company shareholders of record as of a record date to be set shortly before Closing.
CY2023Q2 us-gaap Tangible Capital Required For Capital Adequacy
TangibleCapitalRequiredForCapitalAdequacy
5000001
us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
1496955
us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
3044395
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-bottom: 0.001pt; margin-top: 0px; text-align: justify;;text-indent: 0px;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">USE OF ESTIMATES</div><br/></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-bottom: 0.001pt; margin-top: 0px; text-align: justify;;text-indent: 0px;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-size: 10pt; letter-spacing: 0px; white-space: pre-wrap;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-bottom: 0.001pt; margin-top: 0px; text-align: justify;;text-indent: 0px;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the Company’s financial statements in conformity with generally accepted accounting principles of the United States of Americ<div style="letter-spacing: 0px; top: 0px;;display:inline;">a requi</div>res management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management makes its best estimate of the ultimate outcome for these items based on historical trends and other information available when the financial statements are prepared. Actual results could differ from those estimates.</div></div>
lgiq Operating Segments
OperatingSegments
0.10
CY2023Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P5Y
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 12.0pt;margin-bottom: .001pt;margin-top: 0;text-align: justify;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ACCOUNTS RECEIVABLE AND CONCENTRATION OF RISK</div></div> <div style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 12.0pt;margin-bottom: .001pt;margin-top: 0;text-align: justify;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 12.0pt;margin-bottom: .001pt;margin-top: 0;text-align: justify;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable consists of trade receivables from customers. The Company records accounts receivable at its net realizable value, recognizing an allowance for doubtful accounts based on our best estimate of probable credit losses on our existing accounts receivable. Balances are written off against the allowance after all means of collection have been exhausted and the possibility of recovery is considered remote.</div></div>
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
24853721
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17734610
lgiq Charge For Period For Intangible Assets
ChargeForPeriodForIntangibleAssets
1496955
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19231565
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5622156
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7119111
CY2023Q3 lgiq Amortization Of Intangible Assets Net
AmortizationOfIntangibleAssetsNet
678952
CY2022Q3 lgiq Amortization Of Intangible Assets Net
AmortizationOfIntangibleAssetsNet
1017204
lgiq Amortization Of Intangible Assets Net
AmortizationOfIntangibleAssetsNet
1496955
lgiq Amortization Of Intangible Assets Net
AmortizationOfIntangibleAssetsNet
3044395
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
359841
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1510945
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1510945
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
1510945
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
729480
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5622156
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
253362
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
253362
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
167932
lgiq Charge For Period
ChargeForPeriod
32378
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
200310
CY2023Q3 lgiq Net Property And Equipment
NetPropertyAndEquipment
53052
CY2022Q4 lgiq Net Property And Equipment
NetPropertyAndEquipment
85430
CY2023Q3 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
10368
CY2022Q3 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
13728
us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
32378
us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
39141
CY2023Q3 us-gaap Goodwill Gross
GoodwillGross
5577926
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
5577926
CY2023Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2023Q3 us-gaap Goodwill
Goodwill
5577926
CY2022Q4 us-gaap Goodwill
Goodwill
5577926
CY2023Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
1198074
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
2252383
CY2023Q3 lgiq Allowance For Doubtful Debts
AllowanceForDoubtfulDebts
602751
CY2022Q4 lgiq Allowance For Doubtful Debts
AllowanceForDoubtfulDebts
602751
CY2023Q3 lgiq Recoveries For Accounts Receivable
RecoveriesForAccountsReceivable
595323
CY2022Q4 lgiq Recoveries For Accounts Receivable
RecoveriesForAccountsReceivable
1649632
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
602751
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
155592
lgiq Accounts Receivable Provision For Bad Debts
AccountsReceivableProvisionForBadDebts
0
CY2022 lgiq Accounts Receivable Provision For Bad Debts
AccountsReceivableProvisionForBadDebts
-447159
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
602751
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
602751
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
0
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3934443
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7694799
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19948158
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18136164
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101745947
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101745947
CY2023Q3 lgiq Trade Receivables Held For Sales Amount
TradeReceivablesHeldForSalesAmount
1198074
CY2023Q3 lgiq Retail Land Sales Receivables Stated Interest Rates
RetailLandSalesReceivablesStatedInterestRates
1
CY2023Q3 lgiq Deposit And Other Receivable
DepositAndOtherReceivable
0
CY2022Q4 lgiq Deposit And Other Receivable
DepositAndOtherReceivable
180000
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
84224
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41591
CY2023Q3 lgiq Prepayments Deposits And Other Receivables
PrepaymentsDepositsAndOtherReceivables
84224
CY2022Q4 lgiq Prepayments Deposits And Other Receivables
PrepaymentsDepositsAndOtherReceivables
221591
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34645067
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34645067
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86068463
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2553856
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2169893
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2553856
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2169893
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.21
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.34
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
lgiq Certificate Of Amendment Description
CertificateOfAmendmentDescription
Upon the filing of the Certificate of Amendment, and the resulting effectiveness of the Reverse Stock Split, every 13 outstanding shares of the Company’s Common Stock were, without any further action by the Company, or any holder thereof, combined into and automatically became 1 share of the Company’s Common Stock.
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 lgiq Arithmetic Average Purchase Of Shares Percentage
ArithmeticAveragePurchaseOfSharesPercentage
0.97
CY2022Q1 lgiq Warrants To Purchase Of Common Stock
WarrantsToPurchaseOfCommonStock
631579
CY2022Q1 lgiq Common Stock Percentage
CommonStockPercentage
0.015
CY2022Q1 us-gaap Other Commitment
OtherCommitment
40000000
CY2022Q1 lgiq Ownership Limitation Percentage
OwnershipLimitationPercentage
0.0999
CY2022Q1 us-gaap Stock Issued1
StockIssued1
37000000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
37000000
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
132326
CY2022Q4 us-gaap Share Price
SharePrice
0.0001
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86068463
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31241330
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31241330
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0387
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0387
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2221
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.2221
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2318
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.2318
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.5805
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.5805
CY2021Q3 lgiq Lease Space
LeaseSpace
26954
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
26300
CY2021Q4 lgiq Lease Space
LeaseSpace
12422
CY2021Q4 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
17500
lgiq Maturity Date
MaturityDate
2022-12-31
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
4150
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2023Q3 lgiq Right To Use Assets Operating Leases
RightToUseAssetsOperatingLeases
0
CY2022Q4 lgiq Right To Use Assets Operating Leases
RightToUseAssetsOperatingLeases
58122
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16589
CY2021 lgiq Operating Lease Lease Payments Present Value Percent
OperatingLeaseLeasePaymentsPresentValuePercent
0.0325
us-gaap Adjustment For Amortization
AdjustmentForAmortization
58122
us-gaap Adjustment For Amortization
AdjustmentForAmortization
130248
lgiq Operating Lease Rent Expenses Net
OperatingLeaseRentExpensesNet
76188
lgiq Operating Lease Rent Expenses Net
OperatingLeaseRentExpensesNet
158000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2023Q3 lgiq Right To Use Assets Operating Leases
RightToUseAssetsOperatingLeases
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
lgiq Revenues Percentage
RevenuesPercentage
0.10
CY2023Q3 lgiq Revenues Percentage
RevenuesPercentage
0.10
CY2022Q3 lgiq Revenues Percentage
RevenuesPercentage
0.10
lgiq Revenues Percentage
RevenuesPercentage
0.10
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3265674
CY2023Q3 lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4100373
CY2022Q3 lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11663762
lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17153733
lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1
CY2023Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
1600000
CY2023Q3 lgiq Percentage Of Shares Issued With Restrictions
PercentageOfSharesIssuedWithRestrictions
0.53
CY2023Q3 lgiq Minimum Lock Up Period
MinimumLockUpPeriod
P11M

Files In Submission

Name View Source Status
lgiq-20230930_cal.xml Edgar Link unprocessable
lgiq-20230930_pre.xml Edgar Link unprocessable
lgiq-20230930_def.xml Edgar Link unprocessable
lgiq-20230930_lab.xml Edgar Link unprocessable
0001575872-23-001754-index-headers.html Edgar Link pending
0001575872-23-001754-index.html Edgar Link pending
0001575872-23-001754.txt Edgar Link pending
0001575872-23-001754-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lg025_ex31-1.htm Edgar Link pending
lg025_ex31-2.htm Edgar Link pending
lg025_ex32-1.htm Edgar Link pending
lgiq-20230930.htm Edgar Link pending
lgiq-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
lgiq-20230930_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable